This diabetes drug could let you live past 120
Clinical trials have started for a miracle drug that could help us live into their 120s.
The Food and Drug Administration in America has given the green light to the trials of cheap drug metformin, which is used to treat people with type 2 diabetes, on older people, the Daily Express reported.
Alzheimer's and that they can slow down the ageing process in humans, making those in their 70s as healthy a 50-year-old.
"If you target an ageing process and you slow down ageing then you slow down all the diseases and pathology of ageing as well," said ageing expert Prof Gordon Lithgow, of the Buck Institute for Research on Ageing in California, and one of the study advisers.
Researchers have already proven that the diabetes drug metformin extends the life of animals. Now experts want to see if the same effects can be replicated in humans.
Last year researchers at Cardiff University found that when patients with diabetes were given the drug they lived longer than others without the condition, even though they should have died eight years earlier on average.
The trials are expected to take five to seven years. The drug will aim to attack the process of ageing, rather than individual diseases, one of the project's members, Stuart Jay Olshansky, has explained.
Source: ANI
The Food and Drug Administration in America has given the green light to the trials of cheap drug metformin, which is used to treat people with type 2 diabetes, on older people, the Daily Express reported.
Alzheimer's and that they can slow down the ageing process in humans, making those in their 70s as healthy a 50-year-old.
"If you target an ageing process and you slow down ageing then you slow down all the diseases and pathology of ageing as well," said ageing expert Prof Gordon Lithgow, of the Buck Institute for Research on Ageing in California, and one of the study advisers.
Researchers have already proven that the diabetes drug metformin extends the life of animals. Now experts want to see if the same effects can be replicated in humans.
Last year researchers at Cardiff University found that when patients with diabetes were given the drug they lived longer than others without the condition, even though they should have died eight years earlier on average.
The trials are expected to take five to seven years. The drug will aim to attack the process of ageing, rather than individual diseases, one of the project's members, Stuart Jay Olshansky, has explained.
Source: ANI
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd